Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sb 742881
2. Sb-742881
3. Sb742881
1. 610318-03-1
2. Rgx-104 Hydrochloride
3. Rgx-104
4. Rgx-104 Hcl
5. D32013xltx
6. Sb742881
7. Rgx104 Hcl
8. Rgx-104 (hydrochloride)
9. Unii-d32013xltx
10. Schembl3975944
11. Abequolixron Hydrochloride
12. Sb-742881 Hydrochloride
13. Amy16847
14. Bcp29451
15. Ex-a2710
16. S8689
17. Ac-31569
18. Hy-111498
19. Cs-0042266
20. Rgx-104 Hydrochloride;rgx-104; Rgx104; Rgx 104
21. (3-((3r)-3-(((2-chloro-3-(trifluoromethyl)phenyl)methyl)(2,2- Diphenylethyl)amino)butoxy)phenyl)acetic Acid Hydrochloride
22. (r)-2-(3-(3-((2-chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)amino)butoxy)phenyl)acetic Acid Hydrochloride
23. (r)-2-(3-{3-[[2chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-3-methyl-propoxy}-phenyl)acetic Acid Hydrochloride Salt
24. Benzeneacetic Acid, 3-((3r)-3-(((2-chloro-3-(trifluoromethyl)phenyl)methyl)(2,2-diphenylethyl)amino)butoxy)-, Hydrochloride (1:1)
| Molecular Weight | 632.5 g/mol |
|---|---|
| Molecular Formula | C34H34Cl2F3NO3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 13 |
| Exact Mass | 631.1867838 g/mol |
| Monoisotopic Mass | 631.1867838 g/mol |
| Topological Polar Surface Area | 49.8 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 783 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A RGX-104 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RGX-104, including repackagers and relabelers. The FDA regulates RGX-104 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RGX-104 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A RGX-104 supplier is an individual or a company that provides RGX-104 active pharmaceutical ingredient (API) or RGX-104 finished formulations upon request. The RGX-104 suppliers may include RGX-104 API manufacturers, exporters, distributors and traders.
RGX-104 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RGX-104 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right RGX-104 GMP manufacturer or RGX-104 GMP API supplier for your needs.
A RGX-104 CoA (Certificate of Analysis) is a formal document that attests to RGX-104's compliance with RGX-104 specifications and serves as a tool for batch-level quality control.
RGX-104 CoA mostly includes findings from lab analyses of a specific batch. For each RGX-104 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RGX-104 may be tested according to a variety of international standards, such as European Pharmacopoeia (RGX-104 EP), RGX-104 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RGX-104 USP).
LOOKING FOR A SUPPLIER?
